Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory Phenotype

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Milovanovic, Marija ^a   Volarevic, Vladislav ^a   Ljujic, Biljana ^a   Radosavljevic, Gordana ^a   Jovanovic, Ivan ^a   Arsenijevic, Nebojsa ^a   Lukic, Miodrag L ^a  

^a University of Kragujevac Medical Faculty   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 33; INTERLEUKIN 33 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BAGG ALBINO MOUSE; BRAIN; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNIZATION; LYMPH NODE CELL; LYMPHOID TISSUE; MONONUCLEAR CELL; NONHUMAN; PHENOTYPE; POLARIZATION; PROTEIN EXPRESSION; SPINAL CORD; SPLEEN; WILD TYPE;

ANIMALS; ANTIGENS, CD; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE DELETION; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION; INTERLEUKINS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, INTERLEUKIN; SPINAL CORD;

MUS;

EID: 84866478819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045225     Document Type: Article

References (56)

1. Sospedra M, Martin R, (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23: 683-747.
2. Tominaga S, Jenkins NA, Gilbert DJ, Copeland NG, Tetsuka T, (1991) Molecular cloning of the murine ST2 gene: characterization and chromosomal mapping. Biochim Biophys Acta 1090: 1-8.
3. Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M, (1994) Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 13(5): 1176-1188.
4. Xu D, Chan WL, Leung BP, Huang F, Wheeler R, et al. (1998) Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 187(5): 787-794.
5. Kropf P, Hearth S, Klemenz R, Muller I, (2003) Signalling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection. Infect Immun 71(4): 1961-1971.
6. Liew FY, Pitman NI, McInnes IB, (2010) Disease-associated function of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10: 103-110.
7. Ali S, Mohs A, Thomas M, Klare J, Ross R, et al. (2011) The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-kB To Dampen NF-kB-Stimulated Gene Transcription. J Immunol 187: 1609-1616.
8. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, et al. (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463(7280): 540-544.
9. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, et al. (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464(7293): 1367-1370.
10. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, et al. (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12(7): 631-638.
11. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, et al. (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 107(25): 11489-11494.
12. Espinassous Q, Garcia-de-Paco E, Garcia-Verdugo I, Synguelakis M, von Aulock S, et al. (2009) IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J Immunol 183(2): 1446-1455.
13. Ohno T, Oboki K, Morita H, Kajiwara N, Arae K, et al. (2011) Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation. PLoS One 6(4): e18404 Available: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0018404.
14. Bourgeois E, Van LP, Samson M, Diem S, Barra A, et al. (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 39(4): 1046-1055.
15. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, et al. (2008) IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 181(7): 4780-4790.
16. Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK, (2008) IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes. J Immunol 180(4): 2443-2449.
17. Xu D, Jiang HR, Kewin P, Li Y, Mu R, et al. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 105(31): 10913-10918.
18. Xu D, Jiang HR, Li Y, Pushparaj PN, Kurowska-Stolarska M, et al. (2010) IL-33 exacerbates autoantibody-induced arthritis. J Immunol 184(5): 2620-2626.
19. Pastorelli L, Garg RR, Hoang SB, Spina L, Mattioli B, et al. (2010) Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc Natl Acad Sci U S A 107(17): 8017-8022.
20. Zdravkovic N, Shahin A, Arsenijevic N, Lukic ML, Mensah-Brown EP, (2009) Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin. Mol Immunol 47(1): 28-36.
21. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, et al. (2012) Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol 56(1): 26-33.
22. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5): 479-490.
23. Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, et al. (2011) Production and functions of IL-33 in the central nervous system. Brain Res 1385: 8-17.
24. Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, et al. (2008) Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Bio 84(3): 631-643.
25. Jones LA, Roberts F, Nickdel MB, Brombacher F, McKenzie AN, et al. (2010) IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii. Eur J Immunol 40(2): 426-436.
26. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, et al. (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 107(43): 18581-18586.
27. Li M, Li Y, Liu X, Gao X, Wang YJ, (2012) IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Neuroimmunol 247(1-2): 25-31.
28. Jiang HR, Milovanović M, Allan D, Niedbala W, Besnard AG, et al. (2012) IL-33 attenuates experimental autoimmune encephalomyelitis by suppressing IL-17 and IFN-γ production and inducing alternatively-activated macrophages. Eur J Immunol doi: 10.1002/eji.201141947.
29. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN, (2000) T1/ST2- deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 191: 1069-1076.
30. Stromnes IM, Goverman JM, (2006) Active induction of experimental allergic encephalomyelitis. Nat Protoc 1(4): 1810-1819.
31. Stromnes IM, Goverman JM, (2006) Passive induction of experimental allergic encephalomyelitis. Nat Protoc 1(4): 1952-1960.
32. Wraith DC, Pope R, Butzkueven H, Holder H, Vanderplank P, et al. (2009) A role for galanin in human and experimental inflammatory demyelination. Proc Natl Acad Sci U S A 106(36): 15466-15471.
33. Ponomarev ED, Shriver LP, Maresz K, Pedras-Vasconcelos J, Verthelyi D, et al. (2007) GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J Immunol 178(1): 39-48.
34. Maron R, Hancock WW, Slavin A, Hattori M, Kuchroo V, et al. (1999) Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines. Int Immunol 11(9): 1573-1580.
35. Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, et al. (2008) Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 111(2): 715-722.
36. Yang Y, Weiner J, Liu Y, Smith AJ, Huss DJ, et al. (2009) T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J Exp Med 206(7): 1549-1564.
37. Cebrián M, Yagüe E, Rincón M, López-Botet M, de Landázuri MO, et al. (1988) Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 168(5): 1621-1637.
38. Rothhammer V, Heink S, Petermann F, Srivastava R, Claussen MC,et al. Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE. J Exp Med 208(12): 2465-2476.
39. Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, et al. (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10(5): 514-523.
40. Liston A, Kohler RE, Townley S, Haylock-Jacobs S, Comerford I, et al. (2009) Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J Immunol 182(5): 3121-3130.
41. Bagaeva LV, Rao P, Powers JM, Segal BM, (2006) CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J Immunol 176(12): 7676-7685.
42. Sporici R, Issekutz TB, (2010) CXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, disease. Eur J Immunol 40(10): 2751-2761.
43. Kohler RE, Comerford I, Townley S, Haylock-Jacobs S, Clark-Lewis I, et al. (2008) Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol 18(4): 504-516.
44. O'Connor RA, Li X, Blumerman S, Anderton SM, Noelle RJ, et al. (2012) Adjuvant Immunotherapy of Experimental Autoimmune Encephalomyelitis: Immature Myeloid Cells Expressing CXCL10 and CXCL16 Attract CXCR3+CXCR6+ and Myelin-Specific T Cells to the Draining Lymph Nodes Rather Than the Central Nervous System. J Immunol 188(5): 2093-2101.
45. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204(12): 2803-2812.
46. Syrbe U, Siveke J, Hamann A, (1999) Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression? Springer Semin Immunopathol 21(3): 263-285.
47. Kim CH, Rott LS, Clark-Lewis I, Campbell DJ, Wu L, et al. (2001) Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J Exp Med 193(12): 1373-1381.
48. Chevalier N, Jarrossay D, Ho E, Avery DT, Ma CS, et al. (2004) CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J Neuroimmunol 148(1-2): 11-23.
49. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, et al. (2012) IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 188(3): 1503-1513.
50. Jiang HR, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, et al. (2009) Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol 182(2): 1167-1173.
51. Besnard AG, Togbe D, Guillou N, Erard F, Quesniaux V, et al. (2011) IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol 41(6): 1675-86.
52. Sweet MJ, Leung BP, Kang D, Sogaard M, Schulz K, et al. (2001) A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol166: 6633-6639.
53. Liu J, Buckley JM, Redmond HP, Wang JH, (2010) ST2 negatively regulates TLR2 signaling, but is not required for bacterial lipoprotein-induced tolerance. J Immunol 184(10): 5802-5808.
54. Nakano H, Lin KL, Yanagita M, Charbonneau C, Cook DN, et al. (2009) Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat Immunol 10(4): 394-402.
55. Raϊch-Regué D, Grau-López L, Naranjo-Gómez M, Ramo-Tello C, Pujol-Borrell R, et al. (2012) Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur J Immunol 42(3): 771-782.
56. Gutcher I, Urich E, Wolter K, Prinz M, Becher B, (2006) Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat Immunol 7(9): 946-953.